KR20160055990A - Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same - Google Patents
Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same Download PDFInfo
- Publication number
- KR20160055990A KR20160055990A KR1020140155787A KR20140155787A KR20160055990A KR 20160055990 A KR20160055990 A KR 20160055990A KR 1020140155787 A KR1020140155787 A KR 1020140155787A KR 20140155787 A KR20140155787 A KR 20140155787A KR 20160055990 A KR20160055990 A KR 20160055990A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- mask pack
- gel
- liquid phase
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 239000002537 cosmetic Substances 0.000 title claims abstract description 37
- 238000003860 storage Methods 0.000 title abstract description 6
- 238000002360 preparation method Methods 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 238000005057 refrigeration Methods 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000596504 Tamarindus Species 0.000 claims description 12
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000005487 catechin Nutrition 0.000 claims description 12
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 11
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 11
- 229950001002 cianidanol Drugs 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 229920005862 polyol Polymers 0.000 claims description 6
- 150000003077 polyols Chemical class 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 4
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 229940113120 dipropylene glycol Drugs 0.000 claims description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 abstract description 11
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 230000008859 change Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000037384 skin absorption Effects 0.000 abstract description 5
- 231100000274 skin absorption Toxicity 0.000 abstract description 5
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000001815 facial effect Effects 0.000 abstract 2
- 210000003491 skin Anatomy 0.000 description 46
- 239000007791 liquid phase Substances 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 29
- 239000000499 gel Substances 0.000 description 22
- 239000012071 phase Substances 0.000 description 14
- 239000000017 hydrogel Substances 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 5
- -1 polyglycerin Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001879 gelation Methods 0.000 description 4
- 229920002567 Chondroitin Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- WSSMMNVKLQZMEF-BEKOLJTOSA-N N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O WSSMMNVKLQZMEF-BEKOLJTOSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- FAKFSJNVVCGEEI-UHFFFAOYSA-J tin(4+);disulfate Chemical compound [Sn+4].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O FAKFSJNVVCGEEI-UHFFFAOYSA-J 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/508—Tamarind
Abstract
Description
본 발명은 냉장 온도에서는 고형의 겔상을 유지하고 피부에 도포시 일정 시간 내에액상으로 변하여 향상된 피부 흡수율을 통해 피부 보습 및 진정 효과를 나타낼 수 있는 냉장 보관용 화장료 조성물 및 이를 이용한 마스크 팩 제조방법에 관한 것이다. The present invention relates to a cosmetic composition for refrigeration storage which maintains a solid gel state at a refrigeration temperature and turns into a liquid state within a predetermined time upon application to the skin to exhibit skin moisturizing and soothing effects through an improved skin absorption rate and a method for manufacturing a mask pack using the same will be.
보통 체온이 36.5 ℃일 때 피부는 이보다 5~6 ℃ 낮은 31℃가 정상이다. 그러나 오랫동안 햇빛을 받고 있으면 피부는 40 ℃ 이상으로 올라간다. 이때는 피부 모세혈관이 확장되고 모공이 확대되면서 탄력이 떨어지게 된다. When the body temperature is 36.5 ℃, the skin is normal at 31 ℃, which is 5 ~ 6 ℃ lower than this. However, if you are exposed to sunlight for a long time, your skin will rise to over 40 ℃. At this time, the capillaries of the skin are enlarged and the pores expand, causing the elasticity to fall.
최근에 자외선뿐만 아니라 높은 피부 온도가 진피 층의 콜라겐 분해효소를 증가시키거나 거칠고 칙칙한 피부를 만드는 등 최근 피부온도에 따른 피부노화에 대한 이론이 논문으로 밝혀지고 있으며, 이에 따라 피부온도를 낮춰주고 진정효과를 주는 화장료에 대한 관심이 높아지고 있다.Recently, the theory of skin aging due to recent skin temperature, such as increasing the collagenase of the dermis layer as well as the high skin temperature, or making rough and dull skin, has been disclosed in the paper, thereby lowering the skin temperature, The interest in cosmetics is increasing.
최근 하이드로겔 마스크가 개발되어 피부에 전달되는 유효 성분 등에 대한 피부흡수율을 높이고 피부에 쿨링 효과를 주면서 마스크 시장에서 인기를 얻고 있다. 일예로 대한민국 특허공개 제2014-0061115호는 친수성 고분자로 Na 치환도가 50% 이상인 소듐폴리아크릴레이트를 0.1 내지 1 중량%로 함유하는 스티키 하이드로겔 화장료 조성물에 관한 것으로, 제형 안정성이 우수하면서도 스티키한 점액질을 풍부하게 함유하는 하이드로겔을 형성함으로써 피부에 적용시 밀착성이 우수하여 피부로의 수분 및 성분 흡수를 극대화할 수 있다고 개시하고 있다.Recently, a hydrogel mask has been developed and has gained popularity in the mask market by enhancing the skin absorption rate of the active ingredient and the like delivered to the skin and cooling the skin. For example, Korean Patent Laid-Open Publication No. 2014-0061115 relates to a sticky hydrogel cosmetic composition containing 0.1 to 1% by weight of sodium polyacrylate having a degree of sodium substitution of 50% or more as a hydrophilic polymer and having excellent formulation stability, It has been disclosed that the hydrogel having an enriched mucus is formed, whereby the skin is excellent in adhesion when applied to the skin, thereby maximizing the absorption of moisture and components into the skin.
그러나 하이드로겔이 겔 상태를 그대로 유지한 상태에서 피부에 약물전달을 조절하는 것은, 약물이 피부에 침투하는 데에 상대적으로 장시간이 요구되고 하이드로겔이 피부에 접촉되는 제한된 부분에 한해서 약물이 전달되는 단점이 있다. 이를 극복하기 위하여, 하이드로겔에 침투 증진제를 첨가하거나 피부친화적 조성의 하이드로겔을 만들어 적용시키는 것이 전부였다. However, controlling the drug delivery to the skin while the hydrogel remains in the gel state requires a relatively long time for the drug to penetrate into the skin, and the drug is delivered only to a limited area where the hydrogel contacts the skin There are disadvantages. To overcome this, it was all about adding a penetration enhancer to the hydrogel or making a hydrogel of a skin-friendly composition.
하지만 겔 상태로는 피부와의 친화성에 한계가 있어 미용제가 하이드로겔로부터 피부로 전달되는데 만족할 만한 양과 속도를 가질 수 없는 문제가 있다. 하이드로겔과 피부 사이의 친화성은 하이드로겔 내에 함유되어 있는 미용제 또는 약물이 피부로 전달되는 데 결정적으로 영향을 미치게 된다. 즉, 그 친화성이 크면 하이드로겔에서부터 피부로 미용제 또는 약물의 전달이 용이하고 신속하게 일어날 수 있으나, 친화성이 작으면 그 전달이 충분하지 못하고 느리게 되며, 하이드로겔 마스크의 경우 일정 시간 동안 피부에 접촉시켜야 하고 떼어 내야 하는 번거로움이 있었다.However, in the gel state, there is a limitation in affinity with the skin, and there is a problem that the cosmetic agent can not have a satisfactory amount and speed to be delivered from the hydrogel to the skin. The affinity between the hydrogel and the skin has a crucial influence on the delivery of the cosmetic agent or drug contained in the hydrogel to the skin. That is, if the affinity is large, the delivery of the cosmetic agent or the drug can be easily and rapidly carried out from the hydrogel to the skin, but if the affinity is small, the delivery is not sufficient and slow. In the case of the hydrogel mask, And it was troublesome to remove it.
본 발명의 과제는 일정 시간 경과 후 마스크를 떼어내는 번거로움 없이 피부진정 및 피부 보습 기능을 높이고, 피부 흡수율을 향상시킬 수 있는 특성을 갖는 화장료 조성물 및 이를 이용한 마스크 팩 제조방법을 제공하는 것이다. Disclosure of Invention Technical Problem [8] The present invention provides a cosmetic composition and a method for manufacturing a mask pack using the cosmetic composition, which are capable of enhancing skin calming and skin moisturizing function and improving skin absorption rate without the need to remove the mask after a certain period of time.
상기 과제를 달성하기 위해서, 본 발명은 In order to achieve the above object,
타마린드 검 0.1 내지 3 중량%; 카테킨 0.15 내지 0.45 중량%; 폴리올 1 내지 10 중량% 및 잔부로 물을 포함하는 냉장 보관용 화장료 조성물을 제공한다.0.1 to 3% by weight of tamarind gum; 0.15 to 0.45 wt% catechin; 1 to 10% by weight of a polyol, and water as a remainder.
또한 본 발명은 마스크 몰드 내에 상기 화장료 조성물을 붓고 0 내지 10 ℃의 냉장 조건에서 20분 내지 1시간 동안 보관하여 겔 상의 마스크 팩을 얻는 단계를 포함하는 마스크 팩 제조방법을 제공한다. The present invention also provides a method of manufacturing a mask pack, comprising the step of pouring the cosmetic composition into a mask mold and storing the gel pack in a refrigerated condition at 0 to 10 ° C for 20 minutes to 1 hour to obtain a gel mask pack.
본 발명에 따르면, 저온 조건에서는 겔 상을 유지하고 인체 피부에 도포 시 일정 시간 이내에 액체 상으로 상 변화하므로 마스크를 떼어내는 번거로움 없이 마스크 팩을 이용할 수 있어 사용 편의성이 증진된다. 또한, 향상된 피부 흡수율을 통해 피부 진정 및 보습 효과를 나타낸다. According to the present invention, since the gel phase is maintained at a low temperature condition and the liquid phase changes within a predetermined time upon application to the skin of a human body, the mask pack can be used without the trouble of peeling off the mask. It also shows skin soothing and moisturizing effect through improved skin absorption rate.
도 1은 본 발명의 일실시예에 따른 화장료 조성물의 상온에서의 형상을 촬영한 사진이다.
도 2는 본 발명의 실시예 1 화장료 조성물 도포에 따른 피부수분함유량을 측정한 결과를 나타낸 그래프이다. 1 is a photograph of a shape of a cosmetic composition according to an embodiment of the present invention at room temperature.
Fig. 2 is a graph showing the result of measurement of skin moisture content according to the application of the cosmetic composition of Example 1 of the present invention. Fig.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에서는 온도 조건에 따른 상 변화를 통해 피부 도포 후 떼어내는 번거로움 없이 유효 성분을 피부에 그대로 침투시킬 수 있는 화장료 조성물을 제시한다.The present invention provides a cosmetic composition which can penetrate an active ingredient directly into the skin without the hassle of peeling off the skin after phase change according to temperature conditions.
이를 위해 본 발명의 화장료 조성물은 타마린드 검 0.1 내지 3 중량%; 카테킨 0.15 내지 0.45 중량%; 폴리올 1 내지 10 중량% 및 잔부로 물을 포함한다.To this end, the cosmetic composition of the present invention comprises 0.1 to 3% by weight of tamarind gum; 0.15 to 0.45 wt% catechin; 1 to 10% by weight of polyol and water as the remainder.
상기 타마린드검은 다년생 콩과식물(Tamarindus india L) 종자의 배유를 온수나 열수 또는 알칼리성 수용액으로 추출하였거나 또는 이를 β-갈락토시다아제로 처리한 것으로서 주성분은 다당류이다. 유기산이나 식염 등에 안정하고 가열하여도 분해되지 않으며, 내산성과 내염성이 우수하다. 또한, 상기 타마린드 검은 포도당, 자일로스, 갈락토오즈 등으로 이루어진 복합다당류이다. The endosperm of Tamarindus india L seed is extracted with hot water, hot water or alkaline aqueous solution or treated with? -Galactosidase, and the main component is polysaccharide. It is stable to organic acid and salt, and does not decompose even when heated, and is excellent in acid resistance and salt resistance. It is also a complex polysaccharide composed of tamarind black glucose, xylose, galactose and the like.
이때 타마린드 검은 0.1 내지 3 중량%의 함량으로 포함된다. 만약 그 함량이 상기 범위 미만이면 냉장 보관 조건에서도 겔 상태 유지가 어렵고, 이와 반대로 상기 범위를 초과하면 제형내 안정성에 영향을 미치기 때문에 상기 범위 내에서 사용한다.Wherein the content of tamarind black is in the range of 0.1 to 3% by weight. If the content is less than the above range, it is difficult to maintain the gel state even in a refrigerated storage condition, and if it exceeds the above range, it affects the stability in the formulation.
또한 타마린드 검은 사용 목적을 고려할 때 450,000 Da 내지 750,000 Da의 분자량을 갖는 것이 바람직하다. Also, it is preferable to have a molecular weight of 450,000 Da to 750,000 Da, considering the purpose of using tamarind black.
상기 카테킨은 타마린드 검의 탈수를 위해 첨가된다. 즉, 타마린드 검은 알코올기를 통해 각 분자가 서로 수소 결합되어 있는데, 카테킨의 탈수 작용에 의해 응집되어 저온(4 ℃)에서는 겔 상을 유지하고, 30 ℃ 이상에서는 액상으로 상 변화를 가능하게 한다. The catechin is added for dehydration of tamarind gum. That is, each molecule is hydrogen bonded to each other through a tamarind black alcohol group, which is agglomerated by dehydration action of catechin to maintain a gel phase at a low temperature (4 ° C.) and a liquid phase phase change at a temperature above 30 ° C.
바람직하기로 이러한 카테킨은 전체 화장료 조성물 내에 0.15 내지 0.45 중량%로 포함된다. 만약 0.15 중량% 미만으로 포함되면, 저온 조건에서 겔 상으로 변화가 어렵고, 상기 0.45 중량% 초과로 포함되면 인체 피부 도포 시 액상으로 변화하기 못한다. Preferably, such catechins are included in the total cosmetic composition in an amount of 0.15 to 0.45% by weight. If it is contained in an amount less than 0.15% by weight, it is difficult to change into a gel state at a low temperature, and when it is contained in an amount exceeding 0.45% by weight, it can not be changed into a liquid state upon application of human skin.
이때 폴리올은 보습을 위해 사용하며, 글리세린, 1,3-프로필렌글리콜, 부틸렌글리콜, 디프로필렌글라이콜, 글리세린, 에리스리톨, 크실리톨, 말티톨글리세린, 소르비톨, 폴리글리세린, 폴리에틸렌글리콜, 펜탄디올, 이소프렌글리콜 및 이들의 조합으로 이루어진 군에서 선택된 1종을 사용한다. 이러한 폴리올은 전체 조성물 내에서 1∼10 중량%로 사용하며, 만약 그 함량이 상기 범위 미만이면 충분한 보습력의 확보가 어렵고, 반대로 상기 범위를 초과하여 사용할 경우 사용감이 좋지 않고, 겔 상의 형상과 상의 투명함에 영향을 줄 수 있기 때문에 상기 범위 내에서 적절히 사용한다. At this time, the polyol is used for moisturizing, and it is used for moisturizing, and may be used in the form of a liquid such as glycerin, 1,3-propylene glycol, butylene glycol, dipropylene glycol, glycerin, erythritol, xylitol, maltitol glycerin, sorbitol, polyglycerin, polyethylene glycol, Isoprene glycol, and a combination thereof. Such a polyol is used in an amount of 1 to 10% by weight in the total composition. If the content is less than the above range, it is difficult to secure sufficient moisture resistance. On the other hand, It can be used properly within the above range.
이때 물은 증류수이고, 바람직하게는 탈이온화된 증류수를 사용하며, 전체 중량%를 100 중량%를 만족하도록 잔부로서 사용한다.The water is distilled water, preferably deionized distilled water, and is used as the remainder to satisfy 100 wt% of the total weight%.
본 발명에 따른 화장료 조성물은 0 내지 10 ℃의 냉장 조건에서 겔 상태를 유지하고 상온에서 인체 피부에 도포시 10 분 이내에 액체 상태로 상이 변화한다. The cosmetic composition according to the present invention maintains a gel state at 0 to 10 캜 in a refrigerated condition and changes its phase into a liquid state within 10 minutes when it is applied to human skin at room temperature.
이에 따라 0 내지 10 ℃의 냉장 조건에서 보관하다 상온 조건에서 사용될 수 있다.Accordingly, it can be stored under refrigeration conditions of 0 to 10 ° C and can be used under normal temperature conditions.
구체적으로, 마스크 몰드 내에 화장료 조성물을 붓고 0 내지 10 ℃의 냉장 조건에서 20분 내지 1시간 동안 보관하여 겔 상의 마스크 팩을 얻고, 상온에서 피부에 도포 하면 10분 내에 액체 상태로 상이 변화하면서 떼어낼 번거로움 없이 유효 성분들이 피부에 침투할 수 있다. 즉, 체온 보다 낮은 온도의 두툼한 겔이 액상으로 변할 때, 피부진정을 시킬 뿐만 아니라 피부 보습 효과도 얻을 수 있다.
Specifically, the cosmetic composition is poured in a mask mold and stored in a refrigerated condition at 0 to 10 ° C for 20 minutes to 1 hour to obtain a gel mask pack. When applied to the skin at room temperature, Active ingredients can penetrate the skin without hassle. That is, when the thick gel at a temperature lower than the body temperature changes into liquid, it not only calms the skin but also obtains a skin moisturizing effect.
이외에도, 필요한 경우 이 분야에서 공지된 바의 수용성 활성 성분, 방부제, 산화방지제, 안료, 염료, 향료, 등의 첨가제를 더욱 첨가할 수 있으며, 이때 그 종류 및 함량은 당업자에 의해 적절히 선택될 수 있다In addition, additives such as water-soluble active ingredients, antiseptics, antioxidants, pigments, dyes, fragrances and the like, which are well known in the art, can be further added if necessary, and the kind and content thereof can be suitably selected by those skilled in the art
상기 수용성 활성 성분은 비타민 B 및 그 유도체, 알부틴(arbutin), AA2G(ascorbic acid-2-glucoside)를 포함한 수용성 비타민 C 유도체들, 니아신아마이드(niacinamide), 아데노신(adenosine), N-아세틸글루코스아민(N-acetylglucosamine), 에피칼로카테긴 갈레이트, 각종 수용성 식물 추출물 등이 가능하다. The water soluble active ingredient may be selected from the group consisting of vitamin B and its derivatives, arbutin, water soluble vitamin C derivatives including ascorbic acid-2-glucoside, niacinamide, adenosine, N-acetylglucosamine N-acetylglucosamine), epicalocatechin gallate, various water-soluble plant extracts, and the like.
사용가능한 보습제는 글리세린, 에리스리톨, 크실리톨, 말티톨글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 소르비톨, 폴리글리세린, 폴리에틸렌글리콜, 1,2-펜탄디올, 이소프렌글리콜인 다가 알코올류; 아미노산, 유산나트륨, 피롤리돈카르복실산나트륨 등의 성분, 크실로글루칸, 모과씨, 카라기난, 펙틴, 만난, 카드란, 갈락탄, 델만탄황산, 글리코켄, 케라탄황산, 콘드로이틴, 뮤코이틴황산, 케라토황산, 콘드로이틴, 뮤코이틴황산, 케라토황산, 로커스트빈검, 숙시노글루칸, 카로님산(Calonym acid), 히알론산, 헤파란황산, 히알론산나트륨, 콜라겐, 뮤코다당류, 콘드로이틴황산인 수용성 고분자 물질; 디메틸폴리시록산, 메틸페닐시록산인 실리콘류; 유산균ㆍ비피더스균인 배양상청; 및 이들의 조합으로 이루어진 군에서 선택된 1종을 포함한다. 이러한 보습제는 전체 조성물 내에서 0∼15.0 중량%, 바람직하기로 0.5∼10.0 중량%의 범위로 사용한다.
Usable humectants include polyhydric alcohols such as glycerin, erythritol, xylitol, maltitol glycerin, propylene glycol, 1,3-butylene glycol, sorbitol, polyglycerin, polyethylene glycol, 1,2-pentanediol and isoprene glycol; Amino acid, sodium lactate, and sodium pyrrolidonecarboxylate, and other ingredients such as xyloglucan, corn seed, carrageenan, pectin, mannan, cardan, galactan, deltansulfuric acid, glycocon, keratan sulfate, chondroitin, But are not limited to, tin sulfate, kerato sulfate, chondroitin, mucoitin sulfate, kerato sulfate, locust bean gum, succinoglucan, calonym acid, hyaluronic acid, heparan sulfate, sodium hyaluronate, collagen, mucopolysaccharide, chondroitin A water-soluble polymeric substance which is sulfuric acid; Dimethyl polysiloxane, methylphenyl siloxane; Culture supernatant of lactic acid bacteria and bifidobacteria; And a combination of these. Such a humectant is used in an amount of from 0 to 15.0% by weight, preferably from 0.5 to 10.0% by weight, in the whole composition.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 더욱 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are provided to further understand the present invention, and the present invention is not limited by the examples.
실시예 및 비교예 Examples and Comparative Examples
하기 표 1에 기재된 조성에 따라 화장료 조성물을 제조하였다. 우선 물을 70 ℃까지 가온시킨 뒤, 부틸렌글라이콜, 글리세린, 베타인, 타마린드검을 투입하여 교반용해 시킨다. 그 뒤 별도의 물에 카테킨을 용해시켜 잘 교반한 뒤, 30 ℃까지 냉각시켰다. A cosmetic composition was prepared according to the composition shown in Table 1 below. First, the water is heated to 70 ° C, and then butylen glycol, glycerin, betaine and tamarind gum are added thereto and dissolved by stirring. After that, catechin was dissolved in separate water, stirred well and cooled to 30 ° C.
실험예 1: 겔화(고형 겔상) 현상 Experimental Example 1 Gelation (solid gelation)
실험 실시 후, 각각 온도에 따른 겔화 현상 진행도를 알아보았다. 5 ℃, 25 ℃, 50 ℃ 챔버에 각각 24시간 보관 후 상태를 살펴보았다. 그 결과는 표 2에 나타내었다. After the experiment, the progress of the gelation phenomenon with temperature was examined. 5 ° C, 25 ° C and 50 ° C chambers for 24 hours, respectively. The results are shown in Table 2.
위 표 2에서 볼 수 있듯이 카테킨 함량이 높을수록 5 ℃에서 고형 겔상으로 변화하였다. 하지만, 비교예 5에서 보듯이 카테킨의 함량이 과하면 실온에서도 겔상이 형성 되는 것과 같이 제형에 안정성에도 영향을 미치게 된다.
As shown in Table 2 above, the higher the catechin content, the more the solid gel phase changed at 5 ° C. However, as shown in Comparative Example 5, when the catechin content exceeds the above-mentioned range, the stability of the formulation is affected as well as the gel phase is formed even at room temperature.
실험예 2: 고형 겔상이 되는데 걸리는 시간 (5℃) 및 피부온도 (30℃)에 반응하여 녹는 시간 Experimental Example 2: Melting time in response to time (5 占 폚) and skin temperature (30 占 폚)
상기 실시예 1 내지 3 및 비교예 1 내지 5의 저온(5℃)에서 겔상이 되는데 소요되는 시간과 인체 피부에 도포시 반응하여 액상으로 변화하는데 소요되는 시간을 측정하여 그 결과를 표 3 및 표 4에 나타내었다. The time required to become a gel phase at low temperature (5 ° C) of Examples 1 to 3 and Comparative Examples 1 to 5 and the time required to react with human body skin to change into a liquid phase were measured and the results are shown in Table 3 and Table Respectively.
(5℃)Low temperature
(5 DEG C)
위 표 3에서 볼 수 있듯이, 실시예 1 내지 3 및 비교예 4 내지 5의 화장료 조성물은 5℃에서 모두 겔화되었다. 그러나 카테킨을 포함하지 않거나 그 함량이 적은 비교예 1 내지 3의 화장료 조성물은 겔화가 되지 않고 액상 형태로 있거나, 완전한 겔화가 이루어지지 않은 흐름성 있는 상태로 남아있었다.As shown in Table 3 above, the cosmetic compositions of Examples 1 to 3 and Comparative Examples 4 to 5 were all gelled at 5 占 폚. However, the cosmetic compositions of Comparative Examples 1 to 3, which did not contain catechin or had a low content of catechin, remained in a liquid state without being gelled or in a flowable state without complete gelation.
한편 표 4를 참조하면, 실시예 1 내지 3의 화장료 조성물은 10분 내외로 팩을 사용시 사용하기에 가장 적합한 녹는 시간을 보였다. 반대로 비교예 4와 비교예 5는 피부온도에 반응하여 녹는 시간이 4시간 이상 또는 겔 상태에서 온도에 녹지 않아서 팩으로 사용하기에는 적합하지 않음을 확인하였다.
On the other hand, referring to Table 4, the cosmetic composition of Examples 1 to 3 showed the most suitable time for use when the pack was used within 10 minutes. In contrast, Comparative Example 4 and Comparative Example 5 showed that the dissolution time in response to the skin temperature was not more than 4 hours or in the gel state, which was not suitable for use as a pack.
실험예 3: 관능평가Experimental Example 3: Sensory evaluation
상시 실시예 및 비교예에서 제조한 화장료 조성물의 관능 시험을 실시하였다. 평가 대상으로는 30대 여성 25명을 대상으로 7일동안 저녁 기초화장 단계 시 상기 실시예 및 비교예에서 제조한 화장료 조성물을 사용하도록 하였다. 7일 동안 관찰기간이 끝난 후, 설문조사를 통해 점수로 사용감 만족도를 측정하여, 하기 표 5에 시험 결과를 나타내었다. The sensory test of the cosmetic composition prepared in the Examples and Comparative Examples was carried out. Twenty - five women in their thirties used the cosmetic composition prepared in the above Examples and Comparative Examples for 7 days at the base makeup stage. After 7 days of observing period, satisfaction with the sensation was measured by the questionnaire, and the test results are shown in Table 5 below.
표 5를 참조하면, 냉장 보관후 팩 화장료로 사용함으로 사용감, 퍼짐성, 흡수력 및 전반적인 만족도를 확인한 결과 실시예 1이 가장 만족도가 높은 것으로 나타났다.
As shown in Table 5, the feeling of use, spreadability, absorbency and overall satisfaction were confirmed by being used as a pack cosmetic after refrigerated storage, and as a result, Example 1 was found to be the most satisfactory.
실험예 4: 팩 도포 사용 후 수분력 개선 평가Experimental Example 4: Assessment of improvement of water content after use of pack application
평가대상으로 30세의 여성 30명을 선정하여 세안한 후 스킨 케어를 한 뒤 측정하는 방법과 세안 후 스킨케어를 한 뒤, 저온 상태에서 고형 겔상이 된 실시예 1의 화장료 조성물을 팩으로 도포한 후 10분 후 측정하는 방법으로 각각 왼쪽 및 오른쪽 뺨에 실시하여 피부수분함유량을 측정하였다. 구체적으로는 상기 피험자 10명을 대상으로, 항온항습 조건 25℃/40RH% 에서 15분간 대기 후, 각각 2가지 방법을 이용하여 피부를 적응시켰다. 코네오미터(Corneometer, CM825)를 이용하여, 피부 표면 전기용량(Capacitance)을 3회 반복 측정하였다. 그 평균 결과를 도 2에 나타내었다. 30 women aged 30 years were selected for skin cleansing, followed by skincare, skincare after cleansing, and the packaged cosmetic composition of Example 1 in a solid state at low temperature After 10 minutes, the skin moisture content was measured on the left and right cheeks, respectively. Specifically, 10 subjects were allowed to stand at 25 ° C / 40RH% for 15 minutes under constant temperature and humidity conditions, and skin was adapted using two methods, respectively. The skin surface capacitance was measured three times using a corneometer (CM825). The average results are shown in Fig.
도 2에 나타낸 바와 같이, 스킨케어 후 본 발명의 화장료 조성물을 이용하여 제조된 마스크 팩 도포시 피부 수분량이 상당히 증가한 것을 확인할 수 있었다. As shown in FIG. 2, it was confirmed that the amount of skin moisture increased significantly when applying the mask pack prepared using the cosmetic composition of the present invention after skin care.
Claims (6)
글리세린, 1,3-프로필렌글리콜, 부틸렌글리콜, 디프로필렌글라이콜, 글리세린, 에리스리톨, 크실리톨, 말티톨글리세린, 소르비톨, 폴리글리세린, 폴리에틸렌글리콜, 펜탄디올, 이소프렌글리콜 및 이들의 조합으로 이루어진 군에서 선택된 1종인 것을 특징으로 하는 냉장 보관용 화장료 조성물. The method of claim 1, wherein the polyol
A group consisting of glycerin, 1,3-propylene glycol, butylene glycol, dipropylene glycol, glycerin, erythritol, xylitol, maltitol glycerin, sorbitol, polyglycerin, polyethylene glycol, pentanediol, isoprene glycol, Wherein the cosmetic composition is one selected from the group consisting of:
450,000 Da 내지 750,000 Da의 분자량을 갖는 것을 특징으로 하은 냉장 보관용 화장료 조성물.The method of claim 1, wherein the tamarind black
And has a molecular weight of 450,000 Da to 750,000 Da.
냉장 조건인 0 내지 10 ℃에서 보관되고, 상온 조건에서 사용되는 것을 특징으로 하는 냉장 보관용 화장료 조성물. The cosmetic composition according to claim 1, wherein the cosmetic composition comprises
Wherein the composition is stored at 0 to 10 캜 in a refrigerated condition and is used under normal temperature conditions.
냉장 조건에서는 겔 상태를 유지하고, 상온에서 인체 피부에 도포시 10분 이내에 액체 상태로 상이 변화하는 것을 특징으로 하는 냉장 보관용 화장료 조성물. The cosmetic composition according to claim 1, wherein the cosmetic composition comprises
Wherein the gel state is maintained at a refrigeration condition and the phase changes to a liquid state within 10 minutes upon application to a human skin at room temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140155787A KR20160055990A (en) | 2014-11-11 | 2014-11-11 | Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140155787A KR20160055990A (en) | 2014-11-11 | 2014-11-11 | Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160055990A true KR20160055990A (en) | 2016-05-19 |
Family
ID=56103169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140155787A KR20160055990A (en) | 2014-11-11 | 2014-11-11 | Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160055990A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102104796B1 (en) | 2019-06-24 | 2020-04-27 | 주식회사 로즈랩 | Cosmetic composition for refrigeration storage |
FR3115990A1 (en) * | 2020-11-10 | 2022-05-13 | L'oreal | COMPOSITION COMPRISING AT LEAST ONE POLYSACCHARIDE FROM TAMARIN INDICA SEEDS |
FR3115985A1 (en) * | 2020-11-10 | 2022-05-13 | L'oreal | METHOD FOR MAKING A FACE MASK IN THE FORM OF A GEL |
-
2014
- 2014-11-11 KR KR1020140155787A patent/KR20160055990A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102104796B1 (en) | 2019-06-24 | 2020-04-27 | 주식회사 로즈랩 | Cosmetic composition for refrigeration storage |
FR3115990A1 (en) * | 2020-11-10 | 2022-05-13 | L'oreal | COMPOSITION COMPRISING AT LEAST ONE POLYSACCHARIDE FROM TAMARIN INDICA SEEDS |
FR3115985A1 (en) * | 2020-11-10 | 2022-05-13 | L'oreal | METHOD FOR MAKING A FACE MASK IN THE FORM OF A GEL |
WO2022101195A1 (en) * | 2020-11-10 | 2022-05-19 | L'oreal | Composition comprising at least one tamarindus indica seed polysaccharide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI660744B (en) | Four-dimensional moisturizing composition and the application thereof in preparation of moisturizing cosmetic | |
KR101367608B1 (en) | Emulsified Hydrogel Composition and Preparing Method thereof | |
JP6598207B2 (en) | Water-soluble hyaluronic acid gel and method for producing the same | |
KR101474210B1 (en) | Sticky hydrogel cosmetic composition | |
CN104994849A (en) | Transparent sol, gel composition containing high concentrations of vitamin c and vitamin c derivative | |
JP4015996B2 (en) | Cosmetic composition that has an effect of tightening the skin | |
KR101755306B1 (en) | Cosmetic composition for mask pack | |
KR20120058917A (en) | Gel type cosmetic compositions for spray | |
CN105456057A (en) | Moisture locking and moisturizing composition with mousse texture | |
KR102643993B1 (en) | Mask pack cosmetic for improves the adhesion and moisture | |
KR20210032966A (en) | Methods, compositions and devices related to algae masks | |
KR20160055990A (en) | Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same | |
KR20220095126A (en) | Gel composition and kit comprising physically crosslinked polymer hyaluronic acid or salt thereof | |
KR20130035362A (en) | Hydrogel composition for moisturizing effect and enhancing elasticity on skin according to characteristics of water release | |
EP3777825A1 (en) | Composition of freeze-dried formulation, cosmetic kit for external use on skin including the same, and its use | |
US20110182955A1 (en) | Water- and active ingredient-containing gel | |
JP2003113036A (en) | Gel-like composition | |
JP2544037B2 (en) | Moisturizer and skin cosmetics | |
EP3769750A1 (en) | A hyaluronic acid composition for external use on skin and its use | |
KR20150067823A (en) | Wash-off type pack cosmetic composition | |
KR101270926B1 (en) | Cosmetic composition containing amorphous beads and method thereof | |
US11311472B2 (en) | Topical composition comprising crosslinked hyaluronic acid and a polyacrylate compound | |
KR20090008544A (en) | Scrubbing composition containing alginate salt bead | |
KR101011356B1 (en) | A stick type cosmetic compound containing rosmarinic acid | |
KR20140040001A (en) | Cosmetic composition comprising butter or wax having low melting point |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |